We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
Cap. Flow
-$91.9M
Cap. Flow %
-15.04%
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643

Top Buys

Rank Stock Value
1
BBY icon
Best Buy
BBY
+$2.79M
2
BBWI icon
Bath & Body Works
BBWI
+$2.78M
3
AMD icon
Advanced Micro Devices
AMD
+$2.7M
4
NVDA icon
NVIDIA
NVDA
+$2.4M
5
XOM icon
ExxonMobil
XOM
+$2.28M

Top Sells

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10.9M
2
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$7.99M
3
ORPH
Orphazyme A/S
ORPH
+$5.06M
4
BBIO icon
BridgeBio Pharma
BBIO
+$3.35M
5
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
+$3.25M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.42%
2 Technology 16.02%
3 Healthcare 14.17%
4 Industrials 13.83%
5 Financials 11.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CXW icon
1126
CoreCivic
CXW
$3.19B
$69K 0.01%
+10,601
New +$76.2K
AXAS
1127
DELISTED
Abraxas Petroleum Corp
AXAS
$68K 0.01%
+29,538
New +$69K
ICD
1128
DELISTED
Independence Contract Drilling, Inc.
ICD
$64K 0.01%
+21,922
New +$63.4K
ZSAN
1129
DELISTED
Zosano Pharma Corporation
ZSAN
$64K 0.01%
+3,485
New +$68.1K
AGTC
1130
DELISTED
Applied Genetic Technologies Corporation
AGTC
$62K 0.01%
+15,113
New +$74.2K
VXRT
1131
DELISTED
Vaxart
VXRT
$59K 0.01%
+10,371
New +$66K
FSP
1132
Franklin Street Properties
FSP
$46.8M
$57K 0.01%
+13,132
New +$57.9K
SNDL icon
1133
Sundial Growers
SNDL
$320M
$57K 0.01%
+12,113
New +$41.7K
INDP icon
1134
Indaptus Therapeutics
INDP
$157M
$53K 0.01%
137
+40
+41% +$17.5K
MNKD icon
1135
MannKind Corp
MNKD
$1.32B
$51K 0.01%
16,365
-89,751
-85% -$235K
CHMA
1136
DELISTED
Chiasma, Inc. Common Stock
CHMA
$51K 0.01%
11,654
-5,068
-30% -$21.1K
MUFG icon
1137
Mitsubishi UFJ Financial
MUFG
$254B
$50K 0.01%
11,179
-1,388
-11% -$5.9K
OGEN icon
1138
Oragenics
OGEN
$2.48M
$46K 0.01%
57
+28
+97% +$24.6K
ORTX
1139
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$46K 0.01%
1,070
-65
-6% -$2.91K
JILL icon
1140
J. Jill
JILL
$283M
$45K 0.01%
+11,983
New +$46.5K
GEN
1141
DELISTED
Genesis Healthcare, Inc.
GEN
$41K 0.01%
+85,419
New +$43.1K
SEEL
1142
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$40K 0.01%
7
– –
PLX icon
1143
Protalix BioTherapeutics
PLX
$198M
$36K 0.01%
+10,042
New +$36K
CTXR icon
1144
Citius Pharmaceuticals
CTXR
$18.7M
$35K 0.01%
+1,353
New +$35.3K
RIG icon
1145
Transocean
RIG
$5.82B
$34K 0.01%
14,859
-174,233
-92% -$256K
VATE icon
1146
INNOVATE Corp
VATE
$165M
$33K 0.01%
+1,003
New +$27.9K
AIM
1147
AIM ImmunoTech
AIM
$7.91M
$31K 0.01%
171
-787
-82% -$157K
PHUN icon
1148
Phunware
PHUN
$43.6M
$25K ﹤0.01%
+395
New +$16.2K
NMTR
1149
DELISTED
9 Meters Biopharma
NMTR
$19K ﹤0.01%
+1,130
New +$18.9K
WHWK
1150
Whitehawk Therapeutics
WHWK
$271M
$18K ﹤0.01%
+1,193
New +$25.5K
44 45
46
47 48

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.

  • GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
  • GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
  • GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
  • GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
  • GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
  • GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.